Status: Not yet recruiting
Treating Corneal Thinning Conditions With CCL Vario Riboflavin (CXL)
Study is testing the efficacy of treating corneal thinning conditions with Vitamin B2 (Riboflavin) and the application on UV Light.
Participants needed: 600
Trial details
Phase: Early Phase 1Age: 12+Biological sex: AllType: InterventionalSponsor: Kent Wellish MDUpdated: May 25, 2021
Eligibility criteria
Presence of central or inferior corneal steepening [+17]
Eyes classified as either normal or atypical normal on the severity grading sche... [+7]